Overview

A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils

Status:
Terminated

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate whether fluticasone/formoterol Breath actuated inhaler is effective and well tolerated in the treatment of subjects with fixed airflow obstruction and elevated eosinophils.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Mundipharma Research Limited

Treatments:

Bromides
Fluticasone
Formoterol Fumarate
Glycopyrrolate
Maleic acid
Xhance